SCHEMBL21883582

SCHEMBL21883582

CSc1cccc(F)c1-c1ncc[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 0.40
MTOR P42345 1/20 0.40
ADK P55263 1/20 0.40
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MC4R P32245 1/20 0.36
F2RL1 P55085 3/20 0.33
KDM4E B2RXH2 2/20 0.32
ADRA2A P08913 2/20 0.32
CSNK1A1 P48729 1/20 0.32
TYRO3 Q06418 1/20 0.32
DYRK1B Q9Y463 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP19A1 P11511 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDE3B Q13370 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002691 0.83 NISCH (0.50) NISCHMTORADKALDH1A1MEN1
SCHEMBL19782078 0.79 NISCH (0.44) NISCHMTORADKALDH1A1MEN1
SCHEMBL23492894 0.77 ADRA2A (0.38) NISCHMTORADKALDH1A1MEN1
SCHEMBL28829249 0.76 NISCH (0.43) NISCHMTORADKALDH1A1MEN1
SCHEMBL19769010 0.75 TAAR1 (0.48) NISCHMTORADKALDH1A1MEN1
SCHEMBL22096835 0.75 TAAR1 (0.49) NISCHMTORADKALDH1A1MEN1
SCHEMBL8537576 0.73 CSNK1A1 (0.49) NISCHMTORADKALDH1A1MEN1
SCHEMBL8535959 0.73 CSNK1A1 (0.42) NISCHMTORADKALDH1A1MEN1
Hydrochloric Acid SCHEMBL20204146 0.72 CSNK1A1 (0.47) NISCHMTORADKALDH1A1MEN1
SCHEMBL8541358 0.72 NISCH (0.43) NISCHMTORADKALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597377-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 NISCH 599/4885MTOR 650/4885ADK 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.